How does Melanotan-1 (MT-1) work?
Research overview of how Melanotan-1 (MT-1) works at the molecular level — its proposed mechanism of action, what the published research shows, and where the gaps are.
Proposed mechanism of Melanotan-1 (MT-1)
A synthetic analogue of alpha-MSH researched for melanogenesis and photoprotection studies.
Research on Melanotan-1 (MT-1) focuses on how the peptide interacts with specific biological targets in vitro and in laboratory animal models. Because Melanotan-1 (MT-1) is sold strictly for research use, the mechanism is discussed here only in the context of published scientific literature — not as any suggestion of human efficacy.
What the research literature describes
What is the difference between MT-1 and MT-2?
MT-1 is a linear analogue of alpha-MSH that primarily targets MC1R for melanogenesis. MT-2 is a cyclic analogue with broader receptor activity.
Researchers working with Melanotan-1 (MT-1) typically combine multiple analytical techniques — HPLC for purity, mass spectrometry for identity confirmation, and sometimes NMR for structural verification — before beginning any experimental protocol.
Important research limitations
Most published research on novel peptides is preclinical: conducted in cell lines, tissue samples, or animal models. Results from preclinical research do not automatically translate to human outcomes, and no peptide sold for research use is a substitute for an MHRA-approved medicine. All Peptify products are "for research use only" per UK regulations.
Buy Melanotan-1 (MT-1) for research
99%+ HPLC-verified Melanotan-1 (MT-1) in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.
Frequently asked questions
What is the difference between MT-1 and MT-2?
MT-1 is a linear analogue of alpha-MSH that primarily targets MC1R for melanogenesis. MT-2 is a cyclic analogue with broader receptor activity.